Delivery Order SPE2DR25D9130-SPE2DR26FCEY6
- Not listed
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The Defense Logistics Agency awarded a $2,783.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The place of performance is listed as Park Ridge, IL 60068, and the delivery order represents pharmaceutical supply to support federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, allowing the contractor to compete...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of November 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price contract type, with performance to be completed at the awardee's Park Ridge facility. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- The Defense Logistics Agency awarded a $2,783.55 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for YF-VAX 1 Dose Vials with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order carries no set-aside designation and is to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, serves as the prime contractor and has been registered in the System for Award...
- The Defense Logistics Agency awarded a $10,020.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a specific pharmaceutical procurement supporting the military health system's vaccine supply requirements. The award was made without a set-aside...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a continuation of DLA's pharmaceutical supply operations through its broader procurement...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- SPE2DR25D9130Indefinite Delivery Contract
- SPE2DR25D9130-SPE2DR26FCEY6Delivery Order
The Defense Logistics Agency awarded a $106,897.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The award was issued on October 22, 2025, with an ultimate completion date of November 13, 2025. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., registered in the System for Award Management since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing a comprehensive range of pharmaceuticals and medical consumables to Department of Defense facilities. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The structure enables DLA to issue firm fixed-price delivery orders for diverse pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $106.9k | 10/22/25 |